These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 15331061
1. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. McCullough AJ. Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061 [Abstract] [Full Text] [Related]
2. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [Abstract] [Full Text] [Related]
3. The epidemiology of nonalcoholic fatty liver disease in adults. Clark JM. J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768 [Abstract] [Full Text] [Related]
4. Nonalcoholic fatty liver disease in individuals with severe obesity. Haynes P, Liangpunsakul S, Chalasani N. Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062 [Abstract] [Full Text] [Related]
16. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F. Obes Surg; 2005 Mar 10; 15(3):442-6. PubMed ID: 15826485 [Abstract] [Full Text] [Related]
17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Hepatology; 2004 Aug 10; 40(2):475-83. PubMed ID: 15368453 [Abstract] [Full Text] [Related]
18. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z. Clin Gastroenterol Hepatol; 2009 Nov 10; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819 [Abstract] [Full Text] [Related]
19. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Liver Transpl; 2010 Apr 10; 16(4):431-9. PubMed ID: 20373454 [Abstract] [Full Text] [Related]
20. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nugent C, Younossi ZM. Nat Clin Pract Gastroenterol Hepatol; 2007 Aug 10; 4(8):432-41. PubMed ID: 17667992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]